Neuroleptic Malignant Syndrome vs Serotonin Syndrome: Can They Be Distinguished Without an Underlying Etiology?

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Neuroleptic Malignant Syndrome vs Serotonin Syndrome: Can They Be Distinguished Without an Underlying Etiology?

Article PDF
Author and Disclosure Information

Roy R. Reeves, DO, PhD; Mark E. Ladner, MD; and Percy Smith, PA

Issue
Federal Practitioner - 30(11)
Publications
Topics
Page Number
34-39
Legacy Keywords
neuroleptic malignant syndrome, serotonin syndrome, G.V. (Sonny) Montgomery VAMC, neuropsychiatric disorder, antipsychotic drugs, Roy R. Reeves, Mark E. Ladner, Percy Smith
Sections
Author and Disclosure Information

Roy R. Reeves, DO, PhD; Mark E. Ladner, MD; and Percy Smith, PA

Author and Disclosure Information

Roy R. Reeves, DO, PhD; Mark E. Ladner, MD; and Percy Smith, PA

Article PDF
Article PDF

Issue
Federal Practitioner - 30(11)
Issue
Federal Practitioner - 30(11)
Page Number
34-39
Page Number
34-39
Publications
Publications
Topics
Article Type
Display Headline
Neuroleptic Malignant Syndrome vs Serotonin Syndrome: Can They Be Distinguished Without an Underlying Etiology?
Display Headline
Neuroleptic Malignant Syndrome vs Serotonin Syndrome: Can They Be Distinguished Without an Underlying Etiology?
Legacy Keywords
neuroleptic malignant syndrome, serotonin syndrome, G.V. (Sonny) Montgomery VAMC, neuropsychiatric disorder, antipsychotic drugs, Roy R. Reeves, Mark E. Ladner, Percy Smith
Legacy Keywords
neuroleptic malignant syndrome, serotonin syndrome, G.V. (Sonny) Montgomery VAMC, neuropsychiatric disorder, antipsychotic drugs, Roy R. Reeves, Mark E. Ladner, Percy Smith
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media